TheJobsMapConvergent Therapeutics, Inc. jobs and careers
Cambridge, United States
About Convergent Therapeutics, Inc.
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.
Founded in 2021 by Neil Bander and Philip Kantoff.
- Founded
- 2021
- Employees
- 1 to 10
- Total funding
- $112.2M
- Headquarters
- Cambridge
Leadership
The top of Convergent Therapeutics, Inc.'s org chart, with how many people report into each leader.
Philip Kantoff
CEO
17 reports
Caitlyn Harvey
Vp, Head Of CMC
5 reports
Kevin Zikaras
Vice President, Clinical Development Operations
3 reports
Eric Sullivan
Chief Financial Officer
3 reports
Danielle Quarles
Vice President, Clinical Operations
1 report
Rich Messmann
Chief Medical Officer
Jobs at Convergent Therapeutics, Inc.
No open positions right now. Explore more companies on TheJobsMap.